| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |